XHS
State Street SPDR S&P Health Care Services ETF
SPDR S&P Health Care Services ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Health Care Services Select Industry Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 208.5 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Sep 28, 2011 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| TENET HEALTHCARE CORP | 2.5 % |
| NEOGENOMICS INC | 2.2 % |
| PACS GROUP INC | 2.2 % |
| LIFESTANCE HEALTH GROUP, INC. | 2.2 % |
| U.S. PHYSICAL THERAPY INC | 2.1 % |
| ADDUS HOMECARE CORP | 2.0 % |
| GUARDANT HEALTH, INC. | 2.0 % |
| ACADIA HEALTHCARE CO INC | 2.0 % |
| CHEMED CORP | 2.0 % |
| DAVITA INC | 2.0 % |
Constituent Breakdown
| Number of holdings | 58 |
| Herfindahl-Hirschman Index | 177 |
| Wgt avg mkt cap (mns) | $22,291 |
| Large cap (>$10bn) | 32.0% |
| Mid cap ($2-10bn) | 44.9% |
| Small cap (<$2bn) | 20.5% |
| Developed mkts. | 97.4% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 97.4 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 24.2% | 47.7% | 15.8% | 12.2% | 3.5% | 8.5% | -- | 12.0% |
| Dividend Yield | 0.1% | 0.4% | 0.3% | 0.3% | 0.3% | 0.5% | -- | 0.9% |
| Total Returns | 24.3% | 48.1% | 16.2% | 12.5% | 3.7% | 9.0% | -- | 12.8% | Ann. Volatility | 18.2% | 17.6% | 18.7% | 18.1% | 21.2% | 22.4% | -- | 20.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.55 | 16% |
| MSCI EAFE | 0.37 | 11% |
| MSCI Emg Mkts | 0.14 | 4% |
Liquidity Measures
| Avg. volume (000) | 26 |
| ADV traded (mns) | $4 |
| Turnover | 1.7% |
| Avg. Bid/Ask (% of price) | 0.26% |
Technical Indicators
| 30d moving avg. (EMA) | $131.26 |
| Relative strength (RSI) | 61 |
| MACD/Signal | 1.79/2.59 |
| Bollinger Bands (Upper/Lower) | $137.52/$131.83 |
| Short interest (% of AUM) | 19.4% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XHS |
Expenses vs. XHS |
ALTAR Score™ vs. XHS |
|---|---|---|---|---|
| IHF | iShares U.S. Healthcare Providers ETF | 39.6% | +5 bp | +3.2% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 25.6% | +5 bp | +2.8% |
| FXH | First Trust Health Care AlphaDEX Fund | 20.3% | +27 bp | +1.3% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 20.1% | -6 bp | -1.3% |
| FHLC | Fidelity MSCI Health Care Index ETF | 14.3% | -27 bp | +1.8% |
| VHT | Vanguard Health Care ETF | 14.2% | -26 bp | +1.6% |
| YUNG | Corgi Longevity Consumer ETF | 14.0% | 0 bp | -0.2% |
| RWL | Invesco S&P 500 Revenue ETF | 13.9% | +4 bp | +2.5% |
| SRHQ | SRH U.S. Quality ETF | 13.8% | 0 bp | +2.7% |
| XLV | Health Care Select Sector SPDR | 13.4% | -27 bp | +3.0% |
Risk and Returns: XHS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/9/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.6%
ALTAR SCORE™
21st
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,402 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. XHS's ALTAR Score™ is approximately -0.8 standard
deviations above the category average. This places XHS in the 21st percentile
among funds in the category.
Sell-Side Consensus
$137.14
PRICE TARGET
+1.3%
UPSIDE